Seborrheic Dermatitis Clinical Trials 2023

Seborrheic Dermatitis Clinical Trials 2023

Seborrheic Dermatitis research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in seborrheic dermatitis clinical trials today.

Seborrheic Dermatitis Clinical Trials

Here are the 6 most popular medical studies for seborrheic dermatitis

Popular filter options for seborrheic dermatitis trials

Atopic Dermatitis Clinical Trials

View 75 Atopic Dermatitis medical studies.

AD Clinical Trials

View 75 AD medical studies.

Phase 3 Seborrheic Dermatitis Clinical Trials

View 99 phase 3 seborrheic dermatitis medical studies.

Seborrheic Dermatitis Clinical Trials With No Placebo

View 99 seborrheic dermatitis medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to seborrheic dermatitis

What are the top hospitals conducting seborrheic dermatitis research?

When it comes to finding innovative solutions for seborrheic dermatitis, several hospitals are leading the way in clinical research. In sunny Los Angeles, Dermatology Research Associates is at the forefront with an impressive 14 ongoing trials focused on this common skin condition. This dedicated institution is committed to investigating new treatments and improving the lives of those affected by seborrheic dermatitis. Meanwhile, First OC Dermatology in Fountain Valley has also positioned itself as a top contender, conducting ten active trials aimed at combating this bothersome condition that affects millions worldwide.

Down in San Antonio, Progressive Clinical Research is making significant strides with eight current seborrheic dermatitis trials. This Texas-based institute recognizes the importance of finding effective therapies for this chronic inflammatory disorder that commonly affects areas such as the scalp and face. Additionally contributing to the advancement of treatment options is Dawes Fretzin Clinical Research Group LLC in Indianapolis, where seven active studies are underway specifically targeting seborrheic dermatitis.

And let's not forget about Santa Monica's Clinical Science Institute, where groundbreaking research into seborrheic dermatitis is being conducted through seven ongoing clinical trials. With their collective efforts and dedication to understanding this frustrating skin condition better, these hospitals are offering hope to individuals who have long struggled with its symptoms.

Seborrheic dermatitis may seem like a minor inconvenience compared to other medical conditions; however, it can significantly impact one's quality of life due to its persistent nature and potential social implications. These pioneering institutions recognize that even seemingly benign conditions deserve attention and resources for improved management and patient comfort. Through their tireless pursuit of knowledge and innovation in treating seborrheic dermatitis, they bring us closer to effective remedies that will alleviate discomfort while restoring confidence in those affected by this often underestimated skin issue

Which are the best cities for seborrheic dermatitis clinical trials?

The best cities for seborrheic dermatitis clinical trials include Miami, Florida with 74 active studies focusing on Lebrikizumab, Nemolizumab, etrasimod, and other treatments. Los Angeles, California, Florida with 74 active studies focusing on Lebrikizumab, Nemolizumab, etrasimod, and other treatments. Los Angeles, California is another top city with 49 ongoing trials investigating Lebrikizumab, Upadacitinib, Nemolizumab, and additional interventions. Tampa in Florida follows closely behind with 48 active trials studying Nemolizumab, Lebrikizumab, AK002, and others. Each of these cities provides individuals suffering from seborrheic dermatitis access to cutting-edge clinical research that may lead to significant advancements in care.

Which are the top treatments for seborrheic dermatitis being explored in clinical trials?

Seborrheic dermatitis, a common skin condition characterized by redness and flaking, is the subject of ongoing clinical trials exploring potential treatments. Among the top contenders are:

  • Ketoconazole: An antifungal medication showing promise in combating seborrheic dermatitis.
  • Pimecrolimus: A nonsteroidal anti-inflammatory drug that may help alleviate symptoms associated with this condition.
  • Ciclopirox olamine: An antifungal agent being investigated for its effectiveness in managing seborrheic dermatitis.

These treatments are part of a broader effort to find effective solutions for individuals suffering from seborrheic dermatitis, offering hope for improved quality of life and relief from the bothersome symptoms it presents.

What are the most recent clinical trials for seborrheic dermatitis?

Exciting advancements in the field of seborrheic dermatitis research are bringing new hope to those affected by this condition. Recent clinical trials have explored various treatment options, including a combination therapy that has shown promising results during Phase 2 testing. Additionally, Stage 1_PF-07275315 and IMG-007 Dose 1 have demonstrated potential benefits for treating seborrheic dermatitis patients, with both undergoing Phase 2 evaluation. Other studies have focused on evaluating the effectiveness of Dupilumab and Ruxolitinib in managing symptoms associated with seborrheic dermatitis. These ongoing trials hold promise in expanding our understanding of treatment possibilities and improving outcomes for individuals dealing with this challenging skin condition.

What seborrheic dermatitis clinical trials were recently completed?

A recent completion of a clinical trial brings hope for those affected by seborrheic dermatitis. Sponsored by Arcutis Biotherapeutics, Inc., the trial focused on evaluating the effectiveness of ARQ-154 in treating this common skin condition. Completed in June 2020, this milestone represents a step forward in identifying potential treatments to alleviate the symptoms and improve the quality of life for individuals with seborrheic dermatitis.